Related Experiment Video
Updated: Aug 10, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Regulation of adipocyte differentiation and insulin action with rapamycin
Hye Jin Cho1, Jiyoung Park, Hyun Woo Lee
1School of Biological Sciences, Seoul National University, Seoul 151-742, Republic of Korea.
Abstract:
Here, we demonstrated that inhibition of mTOR with rapamycin has negative effects on adipocyte differentiation and insulin signaling. Rapamycin significantly reduced expression of most adipocyte marker genes including PPARgamma, adipsin, aP2, ADD1/SREBP1c, and FAS, and decreased intracellular lipid accumulation in 3T3-L1 and 3T3-F442A cells, suggesting that rapamycin would affect both lipogenesis and adipogenesis. Contrary to the previous report that suppressive effect of rapamycin on adipogenesis is limited to the clonal expansion, we revealed that its inhibitory effect persisted throughout the process of adipocyte differentiation. Thus, it is likely that constitutive activation of mTOR might be required for the execution of adipogenic programming. In differentiated 3T3-L1 adipocytes, chronic treatment of rapamycin blunted the phosphorylation of AKT and GSK, which is stimulated by insulin, and reduced insulin-dependent glucose uptake activity. Taken together, these results suggest that rapamycin not only prevents adipocyte differentiation by decrease of adipogenesis and lipogenesis but also downregulates insulin action in adipocytes, implying that mTOR would play important roles in adipogenesis and insulin action.
Insights
Rapamycin inhibits adipocyte differentiation and insulin signaling by impacting adipogenesis and lipogenesis. This mTOR inhibitor affects key gene expression and glucose uptake, highlighting mTOR
Area of Science:
- Cell Biology
- Metabolism
- Molecular Endocrinology
Background:
- Mammalian target of rapamycin (mTOR) is a key regulator of cell growth and metabolism.
- Adipocyte differentiation (adipogenesis) and insulin signaling are crucial for metabolic homeostasis.
- The precise role of mTOR in adipogenesis and insulin action requires further elucidation.
Purpose of the Study:
- To investigate the effects of mTOR inhibition using rapamycin on adipocyte differentiation and insulin signaling.
- To determine the impact of rapamycin on adipogenesis, lipogenesis, and insulin-dependent glucose uptake.
- To elucidate the role of mTOR in the execution of adipogenic programming and insulin action.
Main Methods:
- Utilized 3T3-L1 and 3T3-F442A cell lines for adipogenesis studies.
- Administered rapamycin to inhibit mTOR signaling.
- Assessed adipocyte marker gene expression (PPARγ, adipsin, aP2, ADD1/SREBP1c, FAS).
- Quantified intracellular lipid accumulation.
- Evaluated insulin-stimulated phosphorylation of AKT and GSK.
- Measured insulin-dependent glucose uptake.
Main Results:
- Rapamycin significantly reduced adipocyte marker gene expression and intracellular lipid accumulation in both cell lines.
- The inhibitory effect of rapamycin on adipogenesis persisted throughout differentiation, not limited to clonal expansion.
- Chronic rapamycin treatment blunted insulin-stimulated AKT and GSK phosphorylation and reduced glucose uptake in differentiated adipocytes.
- Constitutive mTOR activation appears necessary for adipogenic programming.
Conclusions:
- mTOR inhibition by rapamycin impairs adipocyte differentiation by suppressing adipogenesis and lipogenesis.
- Rapamycin downregulates insulin signaling and glucose uptake in mature adipocytes.
- mTOR plays a critical role in both adipogenesis and the regulation of insulin action.
Related Concept Videos
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways

